Author:
Tabrizi Mohammad,Funelas Cherryl,Suria Hamza
Publisher
Springer Science and Business Media LLC
Reference108 articles.
1. DATAMONITOR USA. Monoclonal antibodies: update 2008. June 2008.
2. La Merie SL. Top 20 biologics. R&D Pipline News. March 2009.
3. Bornstein GG, Queva C, Tabrizi M, van Abbema A, Chavez C, Wang P, et al. Development of a new fully human anti-CD20 monoclonal antibody for the treatment of B-cell malignancies. Investigational New Drugs. 2009. doi:
10.1007/s10637-009-9291-z
.
4. Tabrizi M, Suria H. Application of translational biomarkers in development of antibody-based therapeutics. Drug Discov. 2009;6(1):36–40.
http://wwwtouchbriefingscom/ebooks/A1j0xr/drugseries/resources/indexhtm?referrerUrl=
.
5. Tabrizi MA, Bornstein GG, Klakamp SL, Drake A, Knight R, Roskos L. Translational strategies for development of monoclonal antibodies from discovery to the clinic. Drug Discov Today. 2009;14(5–6):298–305.
Cited by
29 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献